Home › Elan in $1 billion royalty deal with Theravance
 

Keywords :   


Elan in $1 billion royalty deal with Theravance

2013-05-13 09:42:52| Biotech - Topix.net

Elan will make a once off payment of $1 billion to the company in exchange for a 21% stake in future royalty payments from four respiratory programmes which Theravance has developed with GlaxosmithKline.

Tags: with deal billion royalty

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09This weeks lesson: Weaning matters in the cattle market
More »